-
These 94 new drugs approved in the past ten years are still exclusive to the United States. China can only look forward
Time of Update: 2019-12-03
April Chen The United States is still a hot spot for innovative drug research and development From 1996 to November 2019, the cumulative number of new drugs approved by the United States, Europe and J
-
Come again! Hausen, novenol pharmaceutical products linkage, there are two anti-cancer drug prices
Time of Update: 2019-04-30
On April 29, Zhejiang Pharmaceutical Machinery Procurement Center issued a notice that Jiangsu Haosen and Liaoning novenol pharmaceutical actively applied to reduce the online transaction prices of tw
-
Jiangsu Province will cancel the approval document if it fails to pass the consistency evaluation in the clean-up of the generic drug market
Time of Update: 2018-11-06
According to the seminar on encouraging innovation and ensuring the supply of generic drugs held in Nanjing on May 5, our province will intensify efforts to eliminate generic drugs with low quality, h
-
[biopharmaceutical list] 2018 China biopharmaceutical R & D strength list was announced
Time of Update: 2018-07-02
The "2018 China Pharmaceutical R & D strength ranking" released in the third China Pharmaceutical R & D Innovation Summit includes four lists: general list, chemical medicine list, biological medicine
-
[Express News] Thursday, December 14, 2017
Time of Update: 2017-12-14
Academician Wang Erkang won the third China electrochemistry achievement award recently, the electrochemistry Committee of China Chemical Society announced the third China electrochemistry achievement
-
Hengrui has a wide distribution, and the application data of Zhengda Tianqing and dongyanghua drugs in Category 1 & new category 4 are eye-catching: analysis of drug registration trend in 2017
Time of Update: 2017-12-08
2017 is about to pass With the in-depth implementation of drug registration reform, what is the change of enterprise declaration strategy?
Which varieties are more popular?
-
Release of technical guidelines for naming generic names of Chinese patent medicines
Time of Update: 2017-11-29
[policies and regulations of chinapharma.com] on November 28, CFDA issued the technical guidelines for generic name naming of Chinese patent medicines The new Chinese medicine accepted after the issua
-
Drug conversion efficiency: Johnson & Johnson ranked first in PII index for three consecutive years
Time of Update: 2015-03-18
Source: Biovalley 2015-3-18 has always been a simple way to measure the strength of a biomedical company by its turnover, number of new drugs, etc However, how to better measure the innovation of a bi
